Skip to content
DataLookout
Menu

NBS3OMD22NCT07877714

Newborn Screening and Early Diagnosis of AADC Deficiency in the Ligurian Population

StatusRecruiting
PhaseNot specified
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 1 version: 1 with changes below.

  1. Study First Submitted

Endpoints

Primary

Development of an Analytical and Post-Analytical Newborn Screening Protocol for Aromatic L-Amino Acid Decarboxylase Deficiency (AADC-D)
Timeframe: Two years
Incidence of Aromatic L-Amino Acid Decarboxylase Deficiency (AADC-D) in the Neonatal Population of Liguria, Italy
Timeframe: Two years.

Secondary (2)

Establishment of Neonatal 3-O-Methyldopa (3-OMD) Reference Values and Screening Cut-off Values
Development of Second-Tier and Confirmatory Biochemical Testing Methods for AADC-D

Sites

10 sites in 1 country